Braxton Goodrich

Braxton Goodrich is a Managing Director at Timberline Holdings, the Birmingham, Alabama single-family office where he has invested since 2010 and where, per the firm, he "has managed some of Timberline's most successful private equity investments." Timberline was established in 2010 and is associated with the Goodrich family — including Mike Goodrich, the former Chairman and CEO of BE&K, the global engineering and construction firm. The firm runs a diversified book spanning early-stage venture, growth equity, real estate, and controlling positions in mature operating companies.

Before Timberline, Braxton began his career at Charter Business Network, working in medical and educational sales, and later moved into the treasury and finance division at BE&K, the engineering and construction company connected to the family. That treasury/finance grounding informs his work managing Timberline's private-equity and venture positions.

He holds a bachelor's degree from Texas Christian University and an MBA from The George Washington University. Beyond investing, Braxton sits on multiple company boards, including ResBiotic, Undercover Colors, Sprout Pharmaceuticals, and Gas Field Services, and has been active in the Birmingham community (e.g., Jones Valley Teaching Farm).

• Invests through Timberline Holdings, a single-family office whose stated aim is "growth through intelligent, well-researched and innovative investing while minimizing reputational risk."
• Backs a wide range of stages — from early-stage venture (e.g., leading a seed round) to control-position private equity in companies with decades of operating history.
• Sector interests skew toward healthcare and life sciences (ResBiotic, Sprout Pharmaceuticals), consumer/safety technology (Undercover Colors), plus real estate and industrials/energy services (Gas Field Services).
• Values working with "aligned founders and management" for long-term growth and financial stability — signaling a patient, partnership-oriented, board-active style rather than pure financial ownership.
• In his own words on the ResBiotic deal: *"We're proud to be able to support a top notch team commercializing a critical innovation with the potential to transform standards of respiratory care"* — pointing to a preference for strong teams tackling large, global problems.